Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer

被引:23
|
作者
Yang, Guoliang [1 ]
Bondaruk, Jolanta [1 ]
Cogdell, David [1 ]
Wang, Ziqiao [2 ]
Lee, Sangkyou [1 ]
Lee, June Goo [1 ]
Zhang, Shizhen [1 ]
Choi, Woonyoung [3 ]
Wang, Yan [1 ]
Liang, Yu [1 ]
Wang, Gang [1 ]
Wang, Ying [2 ]
Yao, Hui [4 ]
Dadhania, Vipulkumar [1 ]
Gao, Jianjun [5 ]
Logothetis, Christopher [5 ]
Siefker-Radtke, Arlene [5 ]
Kamat, Ashish [6 ]
Dinney, Colin [6 ]
Theodorescu, Dan [7 ]
Kimmel, Marek [8 ]
Wei, Peng [2 ]
Guo, Charles C. [1 ]
Weinstein, John N. [4 ]
McConkey, David J. [3 ]
Czerniak, Bogdan [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[3] Johns Hopkins Univ, Johns Hopkins Greenberg Bladder Canc Inst, Baltimore, MD USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[7] Cedars Sinai, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
[8] Rice Univ, Dept Stat, Houston, TX 77251 USA
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; INFILTRATING IMMUNE CELLS; MOLECULAR CLASSIFICATION; LUMINAL SUBTYPES; CARCINOMA; BREAST; EXPRESSION; BASAL; IDENTIFICATION; DYSREGULATION;
D O I
10.1016/j.isci.2020.101201
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We report a comprehensive molecular analysis of 34 cases of small cell carcinoma (SCC) and 84 cases of conventional urothelial carcinoma (UC), with The Cancer GenomeAtlas cohort of 408 conventional UCbladder cancers used as the reference. SCCs showed mutational landscapes characterized by nearly uniforminactivation of TP53 and were dominated by Sanger mutation signature 3 associated with loss of BRCA1/2 function. SCCs were characterized by downregulation of luminal and basal markers and were referred to as double-negative. Transcriptome analyses indicated that SCCs displayed lineage plasticity driven by a urothelial-to-neural phenotypic switch with a dysregulated epithelial-to-mesenchymal transition network. SCCs were depleted of immune cells, and expressed high levels of the immune checkpoint receptor, adenosine receptor A2A(ADORA2A), which is a potent inhibitor o fimmune infiltration. Our observations have important implications for the prognostication and development of more effective therapies for this lethal bladder cancer variant.
引用
收藏
页数:35
相关论文
共 50 条
  • [1] Dysregulation of Mucosal Microenvironment Drives the Progression of Urothelial Field Effects to Invasive Bladder Cancer
    Czerniak, Bogdan
    Lee, Sangkyou
    Jaksik, Roman
    Kus, Pawel
    Wang, Ziqiao
    Lee, June-Goo
    Navai, Neema
    Dinney, Colin
    McConkey, David
    Guo, Charles
    Wang, Wenyi
    Wei, Peng
    Kimmel, Marek
    LABORATORY INVESTIGATION, 2024, 104 (03) : S925 - S925
  • [2] Chromosome instability and progression in urothelial cell carcinoma of the bladder
    Santos, L
    Pereira, S
    Leite, RP
    Souto, M
    Amaro, T
    Criado, B
    ACTA ONCOLOGICA, 2003, 42 (02) : 169 - 173
  • [3] MORPHOLOGICAL PROGRESSION IN RELAPSING PATIENTS WITH SMALL CELL BLADDER CANCER
    Jad, Moussa Mohammad
    Siefker, Radtke Arlene O.
    Amishi, Y. Shah
    Gao, Jianjun
    Sangeeta, Goswami
    Christopher, J. Logothetis
    Paul, G. Corn
    Ana, Aparicio
    Nizar, M. Tannir
    Ashish, M. Kamat
    Neema, Navai
    Byron, Lee
    Colin, P. N. Dinney
    Bogdan, A. Czerniak
    Charles, C. Guo
    Donna, E. Hansel
    Matthew, T. Campbell
    Omar, Alhalabi
    Nathaniel, R. Wilson
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S30 - S30
  • [4] NON-UROTHELIAL BLADDER NEOPLASMS: SMALL-CELL NEUROENDOCRINE CANCER
    Olivieri, Valerio
    Fortunati, Valentina
    Bellei, Luca
    Del Vecchio, Gianluca
    Massarelli, Massimo
    Ollino, Massimo
    Corongiu, Emanuele
    Forte, Flavio
    Griffa, Daniele
    ANTICANCER RESEARCH, 2020, 40 (08) : 4577 - 4578
  • [5] TFAM drives metabolic plasticity and cisplatin resistance in bladder cancer
    Iqbal, Maheen
    Xu, Tong
    Lu, Yi-Tsung
    Goldkorn, Amir
    CANCER RESEARCH, 2022, 82 (12)
  • [6] AhRR methylation contributes to disease progression in urothelial bladder cancer
    El-Haddad, Nataly W.
    El Kawak, Michelle
    El Asmar, Khalil
    Jabbour, Michel E.
    Moussa, Mohamad A.
    Habib, Rima R.
    Dhaini, Hassan R.
    CANCER BIOMARKERS, 2022, 35 (02) : 167 - 177
  • [7] The role of cell adhesion molecules in the progression of bladder urothelial carcinomas
    Sandulescu, Andrei Stefan
    Stepan, Alex Emilian
    Margaritescu, Claudiu
    Enachescu, Viorela
    Mitroi, George
    Simionescu, Cristiana Eugenia
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2022, 63 (01): : 145 - 151
  • [8] Immunohistochemical Profile of Urothelial and Small Cell Carcinomas of the Bladder
    Jesus Fernandez-Acenero, Ma
    Cordova, Sharon
    Manzarbeitia, Felix
    Medina, Camino
    PATHOLOGY & ONCOLOGY RESEARCH, 2011, 17 (03) : 519 - 523
  • [9] Intrinsic electrical activity drives small-cell lung cancer progression
    Peinado, Paola
    Stazi, Marco
    Ballabio, Claudio
    Margineanu, Michael-Bogdan
    Li, Zhaoqi
    Colon, Caterina I.
    Hsieh, Min-Shu
    Pal Choudhuri, Shreoshi
    Stastny, Victor
    Hamilton, Seth
    Le Marois, Alix
    Collingridge, Jodie
    Conrad, Linus
    Chen, Yinxing
    Ng, Sheng Rong
    Magendantz, Margaret
    Bhutkar, Arjun
    Chen, Jin-Shing
    Sahai, Erik
    Drapkin, Benjamin J.
    Jacks, Tyler
    Vander Heiden, Matthew G.
    Kopanitsa, Maksym V.
    Robinson, Hugh P. C.
    Li, Leanne
    NATURE, 2025, : 765 - 775
  • [10] Biologic markers of urothelial cell cancer of the bladder
    Dobruch, Jakub
    de Reijke, Theo M.
    Borowka, Andrzej
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2010, 63 (02) : 68 - 73